BUSINESS

• New Takeda Global Headquarters Designed for LGBT Inclusion
  July 9, 2018

• Shionogi Regains Exclusive US Rights to Symproic, Seeking New Partner
  July 9, 2018

• No Drug Breaks 100 Billion Yen Mark in FY2017 Japan Sales Ranking: Jiho Tally
  July 6, 2018

• Use of Digital Health Apps Could Reduce Medical Expenditure by 339 Billion Yen Annually: IQVIA
  July 6, 2018

• Sumitomo Dainippon Files Thiotepa for Conditioning Regimen Prior to Autologous HSCT in Pediatric Solid Tumors
  July 5, 2018

• Pfizer Wringing Hands over PMP Eligibility for Lorlatinib; It Might Earn 1st Conditional OK, but It’s “4th” ALK Inhibitor
  July 5, 2018

• Meiji Holdings Makes Kaketsuken’s Successor Company Its Consolidated Subsidiary
  July 4, 2018

• Single-Dose Flu Drug Xofluza Filed in Taiwan: Shionogi
  July 3, 2018

• Takeda Celebrates Grand Opening for New Global Headquarters
  July 3, 2018

• JCR Launches PIII Study of Growject for SHOX Deficiency
  July 3, 2018

• Sawai President Shows Eagerness to “Take Over” To-Be-Withdrawn LLPs
  July 2, 2018

• With Focus on CGRP, Development of New Generation of Preventive Treatments for Migraines Heating Up
  July 2, 2018

• Baxalta Appeals to IP High Court in Hemlibra Patent Lawsuit against Chugai
  July 2, 2018

• Weber Earns 1.2 Billion Yen in FY2017, Logging Western-Level Pay Ratio
  June 29, 2018

• Grilled by Shareholders, Takeda CEO Seeks Understanding for Shire Deal
  June 29, 2018

• AstraZeneca, MSD to Copromote Lynparza from July
  June 29, 2018

• Nippon Shinyaku’s Sakigake-Designated DMD Med Boosts Dystrophin Protein Production in Clinical Studies
  June 29, 2018

• BMS Ties Up with Nagoya Univ. for Immuno-Oncology Biomarker Research
  June 29, 2018

• Eliquis Significantly Lowers Stroke Risk vs Warfarin: Real-World Data
  June 29, 2018

• Mitsubishi Tanabe, Janssen Revise Copromotion Framework for Stelara
  June 29, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 389
• 390
• 391
• 392
• 393
• 394
• 395
• 396
• 397
• …
• Next ›
• 最終 »